Stockscreener 앱 받기
16.06
4.35%
-0.73
시간 외 거래:
16.59
0.53
+3.30%
전일 마감가:
$16.79
열려 있는:
$16.5
하루 거래량:
127.54K
Relative Volume:
0.70
시가총액:
$1.08B
수익:
$-9,000
순이익/손실:
$-68.03M
주가수익비율:
-15.30
EPS:
-1.05
순현금흐름:
$-44.76M
1주 성능:
-7.44%
1개월 성능:
-16.74%
6개월 성능:
-6.57%
1년 성능:
+5.73%
1일 변동 폭
$15.80
$16.77
1주일 범위
$15.80
$17.54
52주 변동 폭
$13.77
$25.00
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
16.06 | 1.13B | -9,000 | -68.03M | -44.76M | -1.05 |
|
ISRG
Intuitive Surgical Inc
|
538.82 | 192.92B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
179.04 | 50.82B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.19 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.40 | 36.34B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
286.94 | 20.13B | 2.96B | 487.70M | 344.00M | 6.6758 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Oppenheimer | Outperform |
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Will Pulse Biosciences Inc. stock recover after recent drop2025 Winners & Losers & AI Driven Stock Reports - newser.com
Will Pulse Biosciences Inc. stock maintain momentum in 2025Quarterly Trade Report & Proven Capital Preservation Methods - newser.com
Real time alert setup for Pulse Biosciences Inc. performanceJuly 2025 Analyst Calls & AI Based Buy and Sell Signals - newser.com
Using data tools to time your Pulse Biosciences Inc. exitJuly 2025 Catalysts & Real-Time Market Trend Scan - newser.com
Sector ETF performance correlation with Pulse Biosciences Inc.Market Movement Recap & Long-Term Investment Growth Plans - newser.com
Measuring Pulse Biosciences Inc.’s beta against major indices2025 Technical Overview & Verified Trade Idea Suggestions - newser.com
Pulse Biosciences Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Quantitative breakdown of Pulse Biosciences Inc. recent moveGap Down & AI Powered Trade Plan Recommendations - newser.com
Pulse Biosciences Inc. stock trend outlook and recovery pathIndex Update & Reliable Price Breakout Alerts - newser.com
Identifying reversal signals in Pulse Biosciences Inc.Market Trend Review & Stepwise Trade Signal Implementation - newser.com
Statistical indicators supporting Pulse Biosciences Inc.’s strengthWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
Why Pulse Biosciences Inc. (6L8) stock benefits from AI revolutionMarket Sentiment Summary & Long-Term Safe Investment Ideas - newser.com
Why hedge funds are buying Pulse Biosciences Inc. stockJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
What recovery options are there for Pulse Biosciences Inc.2025 Momentum Check & Daily Price Action Insights - newser.com
Top chart patterns to watch in Pulse Biosciences Inc.IPO Watch & Community Driven Trade Alerts - newser.com
How high can Pulse Biosciences Inc. stock go2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Using fundamentals and technicals on Pulse Biosciences Inc.July 2025 Trends & Safe Capital Growth Tips - newser.com
Is Pulse Biosciences Inc. (6L8) stock inflation resilientMarket Trend Report & Weekly Top Stock Performers List - newser.com
Is it too late to sell Pulse Biosciences Inc.Insider Selling & Precise Buy Zone Tips - newser.com
Published on: 2025-10-31 21:53:18 - newser.com
Is Pulse Biosciences Inc. (6L8) stock considered safe havenJuly 2025 Opening Moves & Technical Pattern Alert System - newser.com
Visualizing Pulse Biosciences Inc. stock with heatmapsShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
펄스 바이오 주식 (PLSE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Danahy Kevin Patrick | Chief Commercial Officer |
Oct 02 '25 |
Sale |
18.53 |
4,600 |
85,238 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 18 '25 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 19 '25 |
Option Exercise |
1.53 |
400 |
612 |
43,698 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 18 '25 |
Sale |
18.49 |
20,000 |
369,800 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Sep 19 '25 |
Sale |
18.48 |
400 |
7,392 |
43,298 |
| UECKER DARRIN | Chief Technology Officer |
Sep 17 '25 |
Option Exercise |
4.00 |
181,534 |
726,136 |
284,406 |
| UECKER DARRIN | Chief Technology Officer |
Sep 16 '25 |
Option Exercise |
4.00 |
25,000 |
100,000 |
147,872 |
| UECKER DARRIN | Chief Technology Officer |
Sep 16 '25 |
Sale |
16.28 |
25,000 |
407,000 |
122,872 |
| UECKER DARRIN | Chief Technology Officer |
Sep 17 '25 |
Sale |
16.21 |
20,000 |
324,200 |
122,872 |
1.48%
0.69%
자본화:
|
볼륨(24시간):